Literature DB >> 870060

The polar lipids of group B Streptococci. II. Composition and positional distribution of fatty acids.

W Fischer.   

Abstract

1. The polar lipids from group B Streptococci have been isolated. Unless overlapping fractions are worked up on each step molecular species can be lost resulting in a fatty acid composition different from the original one. 2. The lipids were shown to be 1(3),2-diacyl-3(1)-O-alpha-D-glucopyranosyl-sn-glycerol, 1(3),2-diacyl-3(1)-O-[alpha--D-glucopyranosyl-(1,2)-O-alpha-D-glucopyranosyl]-sn-glycerol, 1,2-diacyl-sn-glycero-3-phospho-1'-sn-glycerol, lysylphosphatidylglycerol and 1'-3'-bis(1,2-diacyl-sn-glycero-3-phospho-glycerol. The sterochemical configuration of the phospholipids was achieved by combinations of chemical degradations. 3. The fatty acid composition of group B Streptococci lipids is qualitatively the same as in other Streptococci, but differs by a high content of stearic acid and by a low degree of unsaturation and cyclopropanization. 4. The forementioned polar lipids as well as the glucosyldiphsphatidylglycerol,, which is also found in this organism, showed a very similar composition and the same non-radom positional distribution of fatty acids. Apart from short chain fatty acids the positioning differentiates between saturated and unsaturated fatty acids: short chain and unsaturated fatty acids are accumulated at Position 2, saturated acids are preferentially linked to Position 1. 5. The uniform fatty acid make-up in all polar lipids favours the hypothesis that their diacylglycerol portions are derived from a common phosphatidic acid precursor with negligible postsynthetic rearrangements of the constituent fatty acids.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870060     DOI: 10.1016/0005-2760(77)90046-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Membrane trafficking of the bacterial adhesin GspB and the accessory Sec transport machinery.

Authors:  Cierra Spencer; Barbara A Bensing; Nagendra N Mishra; Paul M Sullam
Journal:  J Biol Chem       Date:  2018-12-04       Impact factor: 5.157

2.  Effect of lipoteichoic acid on thermotropic membrane properties.

Authors:  T Gutberlet; J Frank; H Bradaczek; W Fischer
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.

Authors:  Natalie J Mitchell; Pamela Seaton; Antje Pokorny
Journal:  Biochim Biophys Acta       Date:  2015-10-26

4.  D-Alanylcardiolipin, a major component of the unique lipid pattern of Vagococcus fluvialis.

Authors:  W Fischer; D Arneth-Seifert
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

Review 5.  Group B Streptococcus, phospholipids and pulmonary hypertension.

Authors:  J Curtis; G Kim; N B Wehr; R L Levine
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

Review 6.  Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus.

Authors:  W Fischer
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

7.  Group B streptococcal phospholipid causes pulmonary hypertension.

Authors:  Jerri Curtis; Geumsoo Kim; Nancy B Wehr; Rodney L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

8.  Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus.

Authors:  W Fischer; P Rösel; H U Koch
Journal:  J Bacteriol       Date:  1981-05       Impact factor: 3.490

Review 9.  Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol.

Authors:  Hervé Roy
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

10.  Streptococcus pneumoniae, S. pyogenes and S. agalactiae membrane phospholipid remodelling in response to human serum.

Authors:  Luke R Joyce; Ziqiang Guan; Kelli L Palmer
Journal:  Microbiology (Reading)       Date:  2021-05       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.